Catalyst Pharmaceutical Partners (CPRX)
Create an AlertCatalyst Pharmaceutical Partners Capital Expenditures Quarterly
Catalyst Pharmaceutical Partners Capital Expenditures Quarterly Chart
View Capital Expenditures Quarterly for CPRX.
Start Your YCharts Pro Gold Membership.
Catalyst Pharmaceutical Partners Historical Capital Expenditures Quarterly Data
Pro Data ExportThere is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | Go Pro |
| Sept. 30, 2012 | Go Pro |
| June 30, 2012 | Go Pro |
| March 31, 2012 | Go Pro |
| Dec. 31, 2011 | Go Pro |
| Sept. 30, 2011 | Go Pro |
| June 30, 2011 | Go Pro |
| March 31, 2011 | Go Pro |
| Dec. 31, 2010 | Go Pro |
| Sept. 30, 2010 | Go Pro |
| June 30, 2010 | Go Pro |
| March 31, 2010 | Go Pro |
| Dec. 31, 2009 | Go Pro |
| Sept. 30, 2009 | Go Pro |
About Capex
Capital expenditures are a line item from a company's statement of cash flows (click "Learn More" below for details).
Capex (short for capital expenditures) are incurred when a business spends money to purchase fixed assets or to add value to an existing fixed asset. In accounting, a capital expenditures are added to an asset account, thus increasing the value of the asset.
Examples of capital expenditures include the purchase of a new manufacturing plant, investment in server farms for tech companies, or other purchases of assets expected to help the company earn profits in the future.
Unlike other investments like research and development and marketing spending, capital expenditures are not immediately expensed. Rather, property, plant and equipment acquired using capital expenditures are usually expensed over time through the use of depreciation.
Learn More
View Capital Expenditures Quarterly for CPRX.
Start Your YCharts Pro Gold Membership.
Access over 100 stock metrics like Beta, EV/EBITDA, PE10, Free Cash Flow Yield, KZ Index and Cash Conversion Cycle.
YCharts Pro is only $49/month, and comes with a 14-day free trial.
Get Started NowAlready a YCharts Pro Gold Member? Sign in here.
CPRX Capital Expenditures Quarterly Benchmarks
| Companies | |
|---|---|
| Santarus | Go Pro |
| Lannett Company | Go Pro |
| AVANIR Pharmaceuticals | Go Pro |
CPRX Capital Expenditures Quarterly Rankings
| Overall |
84th percentile 2645 of 16770 |
| Sector |
73rd percentile 379 of 1408 in Healthcare |
| Industry |
70th percentile 45 of 152 in Drug Manufacturers - Specialty & Generic |
CPRX Capital Expenditures Quarterly Range, Past 5 Years
| Minimum | Go Pro | Jun 2008 |
| Maximum | Go Pro | Dec 2012 |
| Average | Go Pro |
